Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

JKAGL: SECTL: SE: 2026 Date: 30th October 2026 BSE Ltd. Department of Corporate Services 25th Floor, Phiroze Jeejeebhoy Towers Dalal Street, Mumbai-400001 Scrip Code: 536493 Through: BSE Listing Centre Dear Sir/ Madam, Re: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ------------------------------------------------------------------------------------------ In compliance with the aforesaid Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e., on 30th October 2026, has approved the transfer of the Company's leasehold rights in respect of non-operational immovable property admeasuring approximately 5.28 acres, situated at IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District, Telangana, in favour of Sai Life Sciences Limited (“the Buyer”), for a total consideration of ₹ 19.80 crore (Rupees Nineteen Crore and Eighty Lakh) only, subject to the terms and conditions agreed between the parties and receipt of necessary approvals and permissions from the relevant authorities, wherever applicable. The proposed transaction is intended to monetise the Company's leasehold rights in the said land, to strengthen Company’s cash flow and optimise financial resources. The details required under Regulation 30 of the Listing Regulations, read with the SEBI Master Circular dated 30th January 2026, reference no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026, is enclosed as Annexure I. Submitted for your information and necessary records. Thanking you and always assuring you of our best cooperation. Yours faithfully, For JK Agri Genetics Ltd. Varsha Singh Company Secretary & Compliance Officer Encl: as above Continuation Sheet 1 Annexure-A Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI circular HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January 2026 S. Particulars Details The amount and percentage of the No revenue or income was generated from turnover or revenue or income and net Company’s said leasehold land rights. worth contributed by such unit or division or undertaking or subsidiary or Accordingly, the revenue or income contribution associate company of the listed entity from the said asset was Nil during the last during the last financial year; financial year. Date on which the agreement for sale The transfer / assignment of Leasehold rights is has been entered into/ the expected expected to be complete within one month. date of completion of sale/disposal; Consideration received from such The total consideration for the transfer of sale/disposal; leasehold rights is ₹19.80 crore (Rupees Nineteen Crore and Eighty Lakh only), to be received by way of demand draft upon completion of transfer. Brief details of buyers and whether Sai Life Sciences Limited (“the Buyer”) is a any of the buyers belong to the company incorporated under the Companies promoter/ promoter group/group Act, 2013, operating in the Contract companies. If yes, details thereof; Research, Development and Manufacturing Organization (CRDMO) sector and serving the global pharmaceutical and biotechnology industries. The Buyer does not belong to the promoter/ promoter group/group companies. Whether the transaction would fall No, the transaction would not fall under within related party transactions? If related party transactions, as the Buyer is not yes, whether the same is done at a related party to the Company. “arm’s length”; Whether the sale, lease or disposal of Yes. The sale of leasehold rights of the land the undertaking is outside Scheme of is not part of a Scheme of Arrangement. Arrangement? If yes, details of the same including compliance with Further, the sale/transfer of leasehold rights regulation 37A of LODR Regulations. of the said land does not attract the provisions of regulation 37A of the LODR Regulations, as it does not constitute an undertaking or substantially the whole of the undertaking for the Company under section 180 (1)(a) of the Companies Act, 2013. Additionally, in case of a slump sale, Not Applicable indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.